Buy, Sell, Or Hold Bristol-Myers Squibb At $60?

Bristol-Myers SquibbBMY’s stock has declined 6% since the beginning of this year (through April 13), compared to a 15% decline for the broader S&P 500. Despite this outperformance, we believe that Bristol-Myers Squibb stock can see some more upside from the current levels of around $58…

About the Author

has written 23414 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com